ONLINE EXPO ENDS WITH RECORD ATTENDANCE: Wound care expert advocates for CNA education on event’s...
By
McKnight's Staff
Mar 22, 2013
An effective, interdisciplinary approach to wound care can reduce rehospitalizations and help facilities avoid litigation, experts said in a webcast on the final day of the McKnight’s Online Expo.
McKnight’s Online Expo offers free continuing education units for the first time
By
James M. Berklan
Mar 01, 2009
In this down-turned economy, when most things seem to be getting more difficult to accomplish or acquire, there is one high-quality endeavor bucking the trend: McKnight’s Online Expo.
Wound care market expected to hit $22 billion by 2022
Sep 06, 2017
The wound care market is expected to grow 3.7% over the next five years to hit $22.01 billion by 2022, according to a new report.
Gentell expands to West Coast
Feb 25, 2015
Gentell Inc. has recently opened a West Coast sales office, with Arnie Anderson as its leader.
Gentell releases latest wound advisor
Apr 14, 2015
Gentell Inc. announced its latest version of Gentell Wound Advisor, 3.15.1, has been released.
Diabetes growth to drive wound market
By
Elizabeth Newman
Nov 01, 2014
A rise in diabetes and obesity will drive the increase in the wound care market over the next four years, a research group asserts.
Smith & Nephew acquires Kalypto Medical
May 09, 2012
Smith & Nephew announced the closing of the acquisition of privately-held Kalypto Medical Inc. The acquisition helps bolster Smith & Nephew’s Negative Pressure Wound Therapy portfolio. Kalypto Medical...
New wound care product used to reduce inflammation
Nov 04, 2014
BIOVANCE, an amniotic membrane allograft derived from a human placenta, is now available for those looking for a wound care product.
Gentell’s Fastcare now includes QAPI reporting
Jan 06, 2015
Gentell Inc. has announced its Fastcare wound documentation and ordering now includes Quality Assurance Performance Improvement reporting capabilities.
Skin closure system debuts
Dec 20, 2017
Chemence Medical Inc. announced it has received Food and Drug Administration clearance to market and sell Exofin Fusion®, a new skin closure system for medium to large wounds.